Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 466

    1.

    Cytotoxic T-cells from T-cell receptor transgenic NOD8.3 mice destroy beta-cells via the perforin and Fas pathways.

    Dudek NL, Thomas HE, Mariana L, Sutherland RM, Allison J, Estella E, Angstetra E, Trapani JA, Santamaria P, Lew AM, Kay TW.

    Diabetes. 2006 Sep;55(9):2412-8.PMID: 16936188 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Perforin and Fas induced by IFNgamma and TNFalpha mediate beta cell death by OT-I CTL.

    McKenzie MD, Dudek NL, Mariana L, Chong MM, Trapani JA, Kay TW, Thomas HE.

    Int Immunol. 2006 Jun;18(6):837-46. Epub 2006 Mar 30.PMID: 16574667 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.

    Kreuwel HT, Morgan DJ, Krahl T, Ko A, Sarvetnick N, Sherman LA.

    J Immunol. 1999 Oct 15;163(8):4335-41.PMID: 10510373 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Perforin-independent beta-cell destruction by diabetogenic CD8(+) T lymphocytes in transgenic nonobese diabetic mice.

    Amrani A, Verdaguer J, Anderson B, Utsugi T, Bou S, Santamaria P.

    J Clin Invest. 1999 Apr;103(8):1201-9.PMID: 10207172 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction.

    Chong MM, Chen Y, Darwiche R, Dudek NL, Irawaty W, Santamaria P, Allison J, Kay TW, Thomas HE.

    J Immunol. 2004 May 1;172(9):5714-21.PMID: 15100317 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes.

    Amrani A, Verdaguer J, Thiessen S, Bou S, Santamaria P.

    J Clin Invest. 2000 Feb;105(4):459-68.PMID: 10683375 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    SOCS-1 protects from virally-induced CD8 T cell mediated type 1 diabetes.

    Barral AM, Thomas HE, Ling EM, Darwiche R, Rodrigo E, Christen U, Ejrnaes M, Wolfe T, Kay TW, von Herrath MG.

    J Autoimmun. 2006 Nov;27(3):166-73. Epub 2006 Oct 10.PMID: 17045460 [PubMed - indexed for MEDLINE]Related articles

    8.

    Islet-specific expression of IL-10 promotes diabetes in nonobese diabetic mice independent of Fas, perforin, TNF receptor-1, and TNF receptor-2 molecules.

    Balasa B, Van Gunst K, Jung N, Balakrishna D, Santamaria P, Hanafusa T, Itoh N, Sarvetnick N.

    J Immunol. 2000 Sep 1;165(5):2841-9.PMID: 10946317 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.
    10.

    Islet rejection in perforin-deficient mice: the role of perforin and Fas.

    Ahmed KR, Guo TB, Gaal KK.

    Transplantation. 1997 Apr 15;63(7):951-7.PMID: 9112346 [PubMed - indexed for MEDLINE]Related articles

    11.

    Xenospecific cytotoxic T lymphocytes: potent lysis in vitro and in vivo.

    Smyth MJ, Kershaw MH, Trapani JA.

    Transplantation. 1997 Apr 27;63(8):1171-8.PMID: 9133481 [PubMed - indexed for MEDLINE]Related articles

    13.

    The role of Fas-FasL in CD8+ T-cell-mediated insulin-dependent diabetes mellitus (IDDM).

    Kreuwel HT, Sherman LA.

    J Clin Immunol. 2001 Jan;21(1):15-8. Review.PMID: 11321233 [PubMed - indexed for MEDLINE]Related articles

    14.

    Absolute requirement of macrophages for the development and activation of beta-cell cytotoxic CD8+ T-cells in T-cell receptor transgenic NOD mice.

    Jun HS, Santamaria P, Lim HW, Zhang ML, Yoon JW.

    Diabetes. 1999 Jan;48(1):34-42.PMID: 9892220 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    A mouse CD8 T cell-mediated acute autoimmune diabetes independent of the perforin and Fas cytotoxic pathways: possible role of membrane TNF.

    Herrera PL, Harlan DM, Vassalli P.

    Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):279-84.PMID: 10618409 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Xenospecific cytotoxic T lymphocytes use perforin- and Fas-mediated lytic pathways.

    Smyth MJ, Sutton VR, Kershaw MH, Trapani JA.

    Transplantation. 1996 Nov 27;62(10):1529-32.PMID: 8958289 [PubMed - indexed for MEDLINE]Related articles

    17.

    Fas and Fas ligand immunolocalization in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes.

    Redd S, Ginn S, Ross JM.

    Histochem J. 2002 Jan-Feb;34(1-2):1-12.PMID: 12365794 [PubMed - indexed for MEDLINE]Related articles

    18.

    Bcl-2 protects against Fas-based but not perforin-based T cell-mediated cytolysis.

    Lee RK, Spielman J, Podack ER.

    Int Immunol. 1996 Jul;8(7):991-1000.PMID: 8757944 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Cytotoxic T cell mechanisms of beta cell destruction in non-obese diabetic mice.

    Kay TW, Dudek NL, Graham K, Estella E, Angstetra E, McKenzie MD, Allison J, Thomas HE.

    Novartis Found Symp. 2008;292:68-78; discussion 78-84, 122-9, 202-3.PMID: 19203093 [PubMed - indexed for MEDLINE]Related articles

    20.

    Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.

    Kataoka T, Shinohara N, Takayama H, Takaku K, Kondo S, Yonehara S, Nagai K.

    J Immunol. 1996 May 15;156(10):3678-86.PMID: 8621902 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data